Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aron Goldhirsch

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
Ecancermedicalscience|June 18, 2015
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive diseaseAron Goldhirsch, Marco Colleoni, Meredith Regan
The Lancet. Oncology|March 6, 2020
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapyLaura Pala, Fabio Conforti, Aron Goldhirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Is adjuvant chemotherapy useful for women with luminal a breast cancer?Alan S Coates, Marco Colleoni, Aron Goldhirsch
The New England Journal of Medicine|November 7, 2007
Drug-induced immune thrombocytopeniaRichard Cathomas, Aron Goldhirsch, Roger von Moos
The Lancet. Oncology|July 3, 2004
Chemotherapy during pregnancy: what is really safe?Fedro Peccatori, Giovanni Martinelli, Oreste Gentilini, et al.
The Oncologist|September 4, 2007
New criteria for selecting elderly patients for breast cancer adjuvant treatment studiesSilvia Dellapasqua, Marco Colleoni, Monica Castiglione, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Immunizing against breast cancer: a new swing for an old swordGiuseppe Curigliano, Marzia Locatelli, Luca Fumagalli, et al.
Breast Cancer (Dove Medical Press)|February 13, 2018
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to dateCarmen Criscitiello, Giulia Viale, Giuseppe Curigliano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2013
Molecular pathways: human leukocyte antigen G (HLA-G)Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Tumori|April 16, 2009
Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?Diana Crivellari, Marco Colleoni, Silvia Dellapasqua, et al.
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
Ecancermedicalscience|June 18, 2015
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive diseaseAron Goldhirsch, Marco Colleoni, Meredith Regan
The Lancet. Oncology|March 6, 2020
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapyLaura Pala, Fabio Conforti, Aron Goldhirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Is adjuvant chemotherapy useful for women with luminal a breast cancer?Alan S Coates, Marco Colleoni, Aron Goldhirsch
The New England Journal of Medicine|November 7, 2007
Drug-induced immune thrombocytopeniaRichard Cathomas, Aron Goldhirsch, Roger von Moos
The Lancet. Oncology|July 3, 2004
Chemotherapy during pregnancy: what is really safe?Fedro Peccatori, Giovanni Martinelli, Oreste Gentilini, et al.
The Oncologist|September 4, 2007
New criteria for selecting elderly patients for breast cancer adjuvant treatment studiesSilvia Dellapasqua, Marco Colleoni, Monica Castiglione, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Immunizing against breast cancer: a new swing for an old swordGiuseppe Curigliano, Marzia Locatelli, Luca Fumagalli, et al.
Breast Cancer (Dove Medical Press)|February 13, 2018
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to dateCarmen Criscitiello, Giulia Viale, Giuseppe Curigliano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2013
Molecular pathways: human leukocyte antigen G (HLA-G)Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Tumori|April 16, 2009
Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?Diana Crivellari, Marco Colleoni, Silvia Dellapasqua, et al.
Pageof 29